Monopar Therapeutics
MNPR
#7537
Rank
ยฃ0.35 B
Marketcap
ยฃ52.74
Share price
-1.84%
Change (1 day)
-24.57%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): -ยฃ1.43

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.46. In 2025 the company made an earnings per share (EPS) of -ยฃ1.41 an increase over its 2024 EPS that were of -ยฃ3.14.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.430.92%
2025-ยฃ1.41-54.99%
2024-ยฃ3.1435.2%
2023-ยฃ2.32-26.75%
2022-ยฃ3.1713.7%
2021-ยฃ2.7925.86%
2020-ยฃ2.2228.89%
2019-ยฃ1.7245.28%
2018-ยฃ1.18-80.5%
2017-ยฃ6.071296.33%
2016-ยฃ0.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA